Event Panel Schedule
Presentations and Panels
Keynote: Current Capitals Markets Overview
Webcast


Gil Bar-Nahum , Managing Director / Jefferies LLC
Dr. Gil Bar-Nahum is a Managing Director in the Global Healthcare Investment Banking Group and leads the International Biotechnology effort at Jefferies. Dr. Bar-Nahum has over 17 years of experience and was an Executive Director in UBS Investment…
Presentations and Panels
What It Takes: A Successful U.S. IPO in A New Virtual World
Webcast


Thomas Hoffmann , Managing Director / Solebury Trout
Tommy’s knowledge of the European markets and his deep relationships with the European investment community has helped many of Solebury Trout’s clients expand their reach into Europe. Conversely, he also assists clients based outside the United…


Franz-Werner Haas , Chief Executive Officer, Chief Operating Officer / CureVac AG
Franz-Werner Haas joined CureVac in June 2012. Before joining CureVac, he was Vice President Operations and Chief Compliance Officer of SYGNIS Pharma AG, where he was responsible for the execution of M&A and capital market transactions…


Robert Puopolo , Partner / Goodwin Procter LLP
Rob Puopolo, a partner in Goodwin’s Life Sciences practice, focuses his practice on representing public and privately held life sciences companies, as well as the venture capital firms, hedge funds and investment banks that focus on these companies.


Gabriel P. Cavazos , Managing Director / SVB Leerink
Gabriel Cavazos has been with Leerink Swann in the Healthcare Banking Division since 2008. Prior to that he worked in M&A at JP Morgan and previously at Merck and Pfizer.
He has a BSc in Cellular & Molecular Biology from the University of…


Bill Kadel , Vice President / Solebury Capital
Bill Kadel is a Vice President at Solebury Capital focusing on equity capital markets within Healthcare and Life Sciences. In this role, Bill advises clients on ECM strategy around IPOs, FOs, SPACs and other equity linked transactions.
Prior to…
Presentations and Panels
Alternatives to IPOs: Reverse Mergers, Direct Listings, SPACs, Cross-Over Financings, and De-Risking Strategies
Webcast


Edwin O'Connor , Partner / Goodwin Procter LLP
Edwin O’Connor, a partner in Goodwin’s Technology Companies Group, has a broad-based capital markets practice and represents issuers and underwriters in public and private corporate finance transactions, both in the United States and internationally…


Thomas Ulmer , CFO / Formerly with Immatics Biotechnologies GmbH
Thomas Ulmer joined Immatics Biotechnologies GmbH in April 2018 from the Merck Group, where he was Chief Financial Officer of the Allergopharma Business Unit. During his tenure with Allergopharma he was the key architect for defining and implementing…


Gil Bar-Nahum , Managing Director / Jefferies LLC
Dr. Gil Bar-Nahum is a Managing Director in the Global Healthcare Investment Banking Group and leads the International Biotechnology effort at Jefferies. Dr. Bar-Nahum has over 17 years of experience and was an Executive Director in UBS Investment…


John Haynor , Managing Director / Solebury Capital
John Haynor is a Managing Director at Solebury Capital where he focuses on the healthcare sector. Before joining Solebury in 2019, John worked in equity capital markets for 15 years most recently as a Managing Director at Jefferies. Prior to…
Presentations and Panels
IPO Readiness: Success Factors and Secrets and Best Practices for European Foreign Private Issuers
Webcast


Dr. Martin Steinbach , Partner, Head of IPO and Listing Services / Ernst & Young
A partner at one of the EY member firms in Germany, Martin is the EY EMEIA IPO Leader as well as the Head of IPO and Listing Services for EY GSA (Germany, Switzerland and Austria). He focuses on IPOs, investor relations, mergers and acquisitions, and…


Joseph Oakenfold , Vice President / Deutsche Bank AG
Joe Oakenfold is the lead salesperson for Deutsche Banks‘ Depositary Receipts business in Europe bringing corporate issuers to the US capital markets and enabling access to the worlds’ largest pool of investment.
With over 20 years’ experience, Joe…


Dirk Gallowsky , Partner / Ernst & Young
Ernst & Young Limited is a global leader in assurance, tax, transaction and advisory services.


Paul van der Bijl / NautaDutilh
Paul van der Bijl specializes in ECM transactions, public M&A, corporate governance of listed companies, anti-takeover defenses and complex cross-border transactions.
Paul has acted as issuer’s counsel in the Nasdaq IPOs of CureVac…